We are proud to announce that our client Asepha raised $4M USD in their seed financing round, led by Glasswing Ventures; co-led by Core Innovation Capital; with participation from Panache Ventures, Redbud VC, MGV.VC; and follow-on investment from Ripple Ventures and Front Row Ventures.
Oziel Law represented Asepha in this transaction with a team led by Allan Oziel, and supported by Dunny Medina and Stephanie Sung.
Asepha provides a professional tool suite purpose-built for the modern pharmacy industry. Their AI-powered solutions and intelligent automation addresses the understaffing crisis experienced by 70% of pharmacies by streamlining core pharmacy operations, cutting pharmacists’ manual workload, and improving patients’ access to care.
They have continued to scale across North America and beyond by expanding their engineering team, elevating product capabilities, and deepening partnerships with leading pharmaceutical organizations, including securing a customer base among multiple Fortune50 companies. This new funding will support their continued enhancement of efficiency, safety and cost savings for patients and pharmacies worldwide, paving the way for Asepha to reach 30 million patients in the coming year.
For learn more, visit: Asepha.ai